Herbal Acne Trial Safety and Evidence Limits in 2026: What the Findings Mean for Adults With Persistent Acne

The 2026 herbal acne trial found encouraging short-term safety results, but it did not prove that the tested supplement reduced persistent adult acne better than placebo. Adults should view the findings as preliminary, not as a reason to replace established acne treatment. The supplement, called LNSA, combined oral extracts of *Phyllanthus emblica* and *Tinospora cordifolia*. Researchers studied it for 12 weeks in adults with postadolescent acne.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Did LNSA improve adult acne?
What do the safety findings show?
Who was not represented?
Does another positive herbal trial change the picture?
How should adults use this evidence?

Did LNSA improve adult acne?

The randomized, double-blind trial included 88 adults who received LNSA or placebo. Participants taking LNSA had dose-related reductions in acne lesions, meaning larger doses produced larger numerical changes. However, none of those reductions differed significantly from placebo on the primary lesion-count outcome.

The Journal of Integrative and Complementary Medicine study therefore did not establish that LNSA works for persistent adult acne. This distinction matters. Improvement within a treatment group is not enough if the placebo group also improves. The comparison between groups determines whether researchers can confidently attribute the difference to the product.

What do the safety findings show?

during the 12-week trial, participants' liver, kidney, and blood-test values remained within reference ranges. Researchers reported no serious or treatment-related adverse events. These results support short-term tolerability only for the people and formulation studied.

They do not establish safety beyond 12 weeks, during pregnancy, alongside other supplements, or with prescription medicines. The absence of reported treatment-related events also does not guarantee that uncommon problems cannot occur. A trial of 88 adults may not reveal effects that arise rarely or after prolonged use.

Who was not represented?

The eligibility rules narrow how widely readers can apply the results. According to the Sri Lanka Clinical Trials Registry protocol, researchers excluded people using acne medicines, long-term medicines, or other herbal supplements.

The study also excluded pregnant or breastfeeding women, people with significant illness, and those with systemic causes of acne. Its safety findings therefore offer limited guidance for many adults who already take medication or have other health concerns.

Does another positive herbal trial change the picture?

A separate 2025 placebo-controlled study tested Kūlaris, a proprietary combination of guggul and konjac extracts. In 100 adults aged 18–40, it produced significantly better lesion and global-assessment results than placebo after 12 weeks, with no reported adverse effects. That result does not validate LNSA because the products contain different ingredients.

It also needs independent confirmation: the Kūlaris extract came from Vidya Herbs, and two study authors were company employees, according to the study's *Clinical, Cosmetic and Investigational Dermatology* disclosure. Together, the trials show why "herbal acne treatment" is too broad a category for a single verdict. Each formulation requires its own evidence, and a positive trial involving a proprietary product cannot establish that other brands or ingredient combinations work.

How should adults use this evidence?

The American Academy of Dermatology found insufficient evidence to recommend plant-based or other alternative acne therapies. Its acne guideline announcement instead supports established topical and systemic treatments.

The FDA also notes that dietary supplements are not preapproved for safety or effectiveness and may interact with medicines. Before trying an oral herbal acne product, use the FDA's supplement guidance as a practical baseline:.

Show a clinician or pharmacist the exact product label.
List every medicine and supplement you take.
Mention pregnancy, breastfeeding, or significant health conditions.
Ask whether the product would replace or delay proven acne care.
Treat a 12-week safety result as short-term evidence, not lifetime reassurance.